RE:RE:RE:RE:Catching breathI agree with Mustang. There needs to be a deal and it needs to be good or we may be in trouble. Volume is still pretty low for a stock with so many outstanding shares so it'll be interesting to see what happens on a high volume day. And yes there are a many warrants that will do more harm than good. Still don't like that patient 7 doesn't exit. Also I'm sure everyone else like me is expecting that patients 2 and 3 are off insulin like patient 1. That is likely baked into the price and the only thing that'll be a surprise is that if the portal vein wasn't used or if the drop in insulin usage is far greater than the first patient pre portal vein injection. There really isn't much else Witkowski can share so personally I think a deal is needed to get the share price into and stay above the 2 dollar range. Could hype or fomo make it go high around the time of the presentation? Yes absolutely and the lack of understanding of the portal vein top up will help but it won't stay there imo.